HeimSVA • NASDAQ
add
Sinovac Biotech Ltd
Við síðustu lokun
6,47 $
Árabil
22,40 $ - 28,18 $
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
NASDAQ
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 60,67 m. | — |
Rekstrarkostnaður | 174,35 m. | — |
Nettótekjur | -3,95 m. | — |
Hagnaðarhlutfall | -6,51 | — |
Hagnaður á hvern hlut | — | — |
EBITDA | -99,97 m. | — |
Virkt skatthlutfall | -5,26% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 10,57 ma. | — |
Heildareignir | 12,90 ma. | — |
Heildarskuldir | 1,39 ma. | — |
Eigið fé alls | 11,51 ma. | — |
Útistandandi hlutabréf | 99,64 m. | — |
Eiginfjárgengi | 0,07 | — |
Arðsemi eigna | -2,60% | — |
Ávöxtun eigin fjár | -2,83% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -3,95 m. | — |
Handbært fé frá rekstri | -219,45 m. | — |
Reiðufé frá fjárfestingum | 218,41 m. | — |
Reiðufé frá fjármögnun | -85,59 m. | — |
Breyting á handbæru fé | -100,08 m. | — |
Frjálst peningaflæði | -78,38 m. | — |
Um
Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China. Its COVID-19 vaccine was the target of a covert disinformation campaign by the US government and a promotional social media astroturfing campaign by the Chinese government. Wikipedia
Framkvæmdastjóri
Stofnsett
2001
Vefsvæði
Starfsfólk
3.037
